Skip to main content
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC logo

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC — Investor Relations & Filings

Ticker · OCTHF ISIN · GB00BMVMRB86 LEI · 2138005SRWT4998BCE35 IL Manufacturing
Open in API
Filings indexed 176 across all filing types
Latest filing 2022-03-03 Regulatory Filings
Country GB United Kingdom
Listing IL OCTHF

About OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

https://www.oxcantech.com/

Oxford Cannabinoid Technologies Holdings PLC was a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based prescription medicines. The company's primary focus was on the pain market, with the goal of developing non-addictive medications to reduce reliance on opioids. Its drug discovery programs targeted the endocannabinoid system (ECS) and included a portfolio of proprietary cannabinoid derivatives, in-licensed compounds, and new chemical entities. According to its website, the company ceased trading and entered administration in May 2025.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1947 characters) and contains the header 'RNS Number : 5881D'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement that does not fit into the specific financial report categories (like 10-K, ER, IR). Therefore, the most appropriate classification is the general regulatory filing category, RNS.
2022-03-03 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1930 characters) and contains the header 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. It announces a 'Price Monitoring Extension' for a security. This is a brief, specific regulatory announcement that does not fit the definitions for a full report (10-K, IR), an earnings release (ER), or a management change (MANG). Since it is a direct, non-standard regulatory notification distributed via the RNS system, the most appropriate classification is the general regulatory filing category, RNS.
2022-03-03 English
Half Year Report for the period ended 30 November 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited interim report for the 6 months ended 30 November 2021' for Oxford Cannabinoid Technologies Holdings plc. It contains a CEO's Interim Management Statement, financial highlights, and references to consolidated financial statements (Income, Position, Equity, Cash Flows). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-02-22 English
Interim Results: 6 months to 30 November 2021
Report Publication Announcement Classification · 95% confidence The document is an announcement of 'Interim Results for the six months ended 30 November 2021' for Oxford Cannabinoid Technologies Holdings plc. It contains operational and financial highlights, a CEO statement, and details regarding analyst briefings. While it provides a summary of financial performance, it functions as a press release announcing the availability of the full interim report (which is referenced as being available on the company website). According to the 'Menu vs Meal' rule, this is a report publication announcement rather than the full financial report itself. H1 2021
2022-02-22 English
Requisition of General Meeting
Regulatory Filings Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 1916C' and the footer referencing RNS/London Stock Exchange) dated February 18, 2022. The core content is the announcement that the Board received a letter requisitioning a General Meeting to remove and appoint directors, citing sections 303 and 304 of the Companies Act 2006. This document is an official notice regarding a shareholder-requested meeting and proposed board changes, which is a specific corporate governance event. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since the document explicitly details the request for a General Meeting and the proposed resolutions for director changes, it relates closely to shareholder voting and board composition. However, the primary action described is the *requisition* of a meeting, not the results of a vote (DVA) or the proxy materials sent out beforehand (PSI). Given the content focuses on the mechanics of calling a meeting based on shareholder demand concerning board composition, it fits best under the general category of corporate governance announcements or regulatory filings. Since the document details the request for a General Meeting, which is a precursor to voting, and involves management/board changes, it is most closely related to governance or a general regulatory filing. Because it is a formal announcement of a significant corporate action (requisitioning a meeting to change the board) published via RNS, and doesn't perfectly match the specific definitions for AGM-R (which implies the meeting materials themselves) or MANG (which implies *announcement of changes* rather than the *process* to force changes), the most appropriate classification is the general regulatory filing category (RNS), or potentially Governance Information (CGR) or Board/Management Information (MANG). Given the explicit reference to the Companies Act and the formal nature of the requisition, RNS is a safe classification, but the subject matter is highly specific to board composition changes initiated by shareholders. Since the document announces the *requisition* of a meeting to vote on director changes, and the resolutions themselves are included, it strongly relates to the governance structure. If the document were solely about the results of the vote, it would be DVA. If it were about the final board composition, MANG. As it is the formal notice of the requisition, RNS is the most accurate catch-all for formal regulatory notices not covered elsewhere, although CGR is also plausible. I will select RNS as the primary regulatory announcement type.
2022-02-18 English
Notice of Interim Results & Investor Presentations
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 8098A) on February 7, 2022. The title is "Notice of Interim Results & Analyst and Investor Presentations". It explicitly states the company "intends to announce results for the half year ended 30 November 2021 on Tuesday 22 February 2022." It then details schedules for an Analyst Briefing, an Investor Presentation, and another webinar. Since this document is an announcement *about* the upcoming release of interim results and associated events, rather than the full interim report itself (which would likely be classified as 'IR'), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific nature of announcing the publication schedule and associated events, RPA is a strong candidate, but RNS is the general regulatory announcement category. Since the content is primarily an announcement of future events related to results, and it is distributed via RNS, classifying it as RNS (the general regulatory announcement fallback) or RPA (announcement of report publication) is appropriate. RPA is more specific to the context of announcing results/reports. I will choose RPA as it specifically announces the publication of results and related presentations.
2022-02-07 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.